Redeye lowers its Base Case, mainly due to lost optionality regarding Russia and somewhat higher personnel costs than expected. The optionality is also adjusted in our Bull Case. However, Redeye maintains its positive view about CSEC and sees a 200% upside in our Base Case.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases